Company intelligence / Profile preview

Nordic Biotic

Warsaw/Warszawa, Mazowieckie, Polandnordicbiotic.com ↗

Ownership: Private
Development stage: Commercial

Overview

Nordic Biotic develops clinically proven probiotic products targeting osteopenia, cholesterol management, iron absorption, constipation, and Hashimoto’s disease. Their solutions are supported by randomized, double-blind, placebo-controlled human clinical trials. Recent studies include positive results for bone mineral density improvement in postmenopausal women and immune support during acute respiratory tract infections.

Therapeutic areas: EndocrinologyHematologyGastroenterologyCardiovascularWomen's Health
Modalities: Probiotics (beneficial microbiome bacteria)
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Nordic Biotic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nordic Biotic.

Explore the full profile